[Form 4] Clene Inc. Insider Trading Activity
Clene Inc. reporting person Morgan R. Brown, who is identified as an officer (Chief Financial Officer), was granted a stock option award on 09/25/2025 for 10,000 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The award vests in 12 equal monthly installments starting 10/25/2025 until fully vested. The table lists the underlying common shares as 10,000 and shows the option term referencing 09/24/2035. The Form 4 reports the grant as an acquisition of derivative securities and indicates direct ownership following the grant of 10,000 options.
Clene Inc. Il soggetto segnalante, Morgan R. Brown, identificato come dirigente (Chief Financial Officer), ha ricevuto una concessione di stock option il 25/09/2025 per 10,000 azioni ordinarie ai sensi del Clene Inc. Amended 2020 Stock Plan, con un prezzo di esercizio di $6.05 per azione. La concessione matura in 12 rate mensili uguali a partire dal 25/10/2025 fino al completo vesting. La tabella elenca le azioni ordinarie sottostanti come 10,000 e mostra il termine dell’opzione con riferimento al 09/24/2035. Il Form 4 riporta l’assegnazione come acquisizione di strumenti derivati e indica la proprietà diretta a seguito dell’assegnazione di 10,000 opzioni.
Clene Inc. La persona reportante, Morgan R. Brown, identificada como funcionario (Director financiero), recibió una concesión de opción sobre acciones el 25/09/2025 por 10,000 acciones comunes bajo el Clene Inc. Amended 2020 Stock Plan, con un precio de ejercicio de $6.05 por acción. La adjudicación se consolida en 12 cuotas mensuales iguales a partir del 25/10/2025 hasta que esté completamente consolidada. La tabla lista las acciones comunes subyacentes como 10,000 y muestra el plazo de la opción haciendo referencia al 24/09/2035. El Formulario 4 reporta la concesión como adquisición de valores derivados y indica propiedad directa tras la concesión de 10,000 opciones.
Clene Inc. 보고자 모건 R. 브라운은 임원으로 식별되며(최고재무책임자), 2025년 9월 25일에 10,000주의 보통주에 대한 스톡옵션 수여를 받았고, Clene Inc. Amended 2020 Stock Plan에 따라 주당 행사 가격은 $6.05이다. 수여는 12회의 균등한 월간 분할로 2025년 10월 25일부터 시작하여 완전 vest될 때까지 진행된다. 표는 기초 보통주를 10,000주로 기재하고, 옵션의 기간은 2035년 9월 24일을 참조로 보여준다. Form 4는 수여를 파생증권 취득으로 보고하며, 10,000개의 옵션을 부여 받은 직후 직접 소유권을 나타낸다.
Clene Inc. La personne dénommée par le rapport, Morgan R. Brown, identifiée comme fonctionnaire (Directeur financier), a reçu une attribution d’options sur actions le 25/09/2025 pour 10 000 actions ordinaires dans le cadre du Clene Inc. Amended 2020 Stock Plan, à un prix d’exercice de $6,05 par action. L’attribution veste en 12 versements mensuels égaux à partir du 25/10/2025 jusqu’à ce qu’elle soit entièrement acquise. Le tableau répertorie les actions ordinaires sous-jacentes comme 10 000 et montre la durée de l’option faisant référence au 24/09/2035. Le Form 4 rapporte l’attribution comme une acquisition de valeurs dérivées et indique une propriété directe suite à l’octroi de 10 000 options.
Clene Inc. Die meldende Person Morgan R. Brown, identifiziert als Beauftragter (Chief Financial Officer), erhielt am 25.09.2025 eine Aktienoptionszuteilung über 10.000 Stammaktien gemäß dem Clene Inc. Amended 2020 Stock Plan zu einem Ausübungspreis von $6,05 pro Aktie. Die Zuteilung vested in 12 gleichen monatlichen Raten ab dem 25.10.2025 bis zur vollständigen Vestung. Die Tabelle führt die zugrunde liegenden Stammaktien mit 10.000 auf und zeigt die Optionslaufzeit mit Bezug auf das 24.09.2035. Das Form 4 meldet die Gewährung als Erwerb derivativer Wertpapiere und gibt nach der Gewährung von 10.000 Optionen unmittelbaren Eigentum an.
Clene Inc. الشخص المبلغ عنه Morgan R. Brown، المعرّف كموظف (كبير التنفيذيين الماليين)، قد مُنِحَت له منحة خيار أسهم بتاريخ 25/09/2025 لما مجموعه 10,000 سهم من الأسهم العادية بموجب خطة الأسهم المعدلة لعام 2020 من Clene Inc. وبسعر تمرين قدره $6.05 للسهم. تحدث vesting على مدار 12 قسطاً شهرياً متساوياً ابتداءً من 25/10/2025 حتى يتم vest بالكامل. يدرج الجدول الأسهم العادية الأساسية كـ 10,000 ويُظهر مدة الخيار بالإشارة إلى 24/09/2035. يُبلغ شكل Form 4 عن المنحة باعتبارها اكتساباً لأوراق مالية مشتقة ويشير إلى الملكية المباشرة بعد منح 10,000 خيار.
Clene Inc. 报告人 Morgan R. Brown，被识别为一位高管（首席财务官），于2025/09/25获得一项股票期权奖励，涉及10,000股普通股，依据 Clene Inc. 的 Amended 2020 Stock Plan，行使价为每股$6.05。该奖励在12个相等的月度分期中完成 vesting，自2025/10/25起直至完全 vest。表格将基础普通股列为10,000，并显示该期权期限，参照2035/09/24。Form 4 将授予报告为对衍生证券的取得，并指明在授予10,000份期权后直接持有。
- Officer retention aligned: Grant vests monthly over 12 months, which supports near-term retention of the CFO
- Transparent disclosure: Form 4 documents the grant date, exercise price ($6.05), and number of options (10,000)
- Limited context for materiality: Filing does not disclose total outstanding shares or prior insider holdings, so dilution impact is unknown
- Short vesting schedule: Monthly vesting over one year may provide limited long-term alignment compared with multi-year vesting (disclosed as fact)
Insights
TL;DR: A routine executive equity grant: 10,000 options at $6.05 with monthly vesting over one year; modest, typical retention compensation.
The award is a standard option grant to the company's CFO under the 2020 Stock Plan. It vests monthly over 12 months, aligning short-term retention and incentive. The exercise price of $6.05 is explicitly stated. The option term references a 10-year horizon to 09/24/2035 as shown in the filing. Without outstanding share counts or prior insider holdings disclosed here, the absolute dilution or percentage impact cannot be determined from this Form 4 alone.
TL;DR: Governance action appears routine: an officer-level equity grant with standard vesting, documented on Form 4.
The grant follows customary governance practice of documenting officer compensation-related equity transactions on Form 4. Monthly vesting over 12 installments is more front-loaded than multi-year cliffs but permissible under many plans. The filing identifies the reporting person as the CFO and reports direct beneficial ownership of the granted options. The filing does not include plan limits, prior grants, or aggregate insider holdings, so broader governance implications cannot be assessed solely from this document.
Clene Inc. Il soggetto segnalante, Morgan R. Brown, identificato come dirigente (Chief Financial Officer), ha ricevuto una concessione di stock option il 25/09/2025 per 10,000 azioni ordinarie ai sensi del Clene Inc. Amended 2020 Stock Plan, con un prezzo di esercizio di $6.05 per azione. La concessione matura in 12 rate mensili uguali a partire dal 25/10/2025 fino al completo vesting. La tabella elenca le azioni ordinarie sottostanti come 10,000 e mostra il termine dell’opzione con riferimento al 09/24/2035. Il Form 4 riporta l’assegnazione come acquisizione di strumenti derivati e indica la proprietà diretta a seguito dell’assegnazione di 10,000 opzioni.
Clene Inc. La persona reportante, Morgan R. Brown, identificada como funcionario (Director financiero), recibió una concesión de opción sobre acciones el 25/09/2025 por 10,000 acciones comunes bajo el Clene Inc. Amended 2020 Stock Plan, con un precio de ejercicio de $6.05 por acción. La adjudicación se consolida en 12 cuotas mensuales iguales a partir del 25/10/2025 hasta que esté completamente consolidada. La tabla lista las acciones comunes subyacentes como 10,000 y muestra el plazo de la opción haciendo referencia al 24/09/2035. El Formulario 4 reporta la concesión como adquisición de valores derivados y indica propiedad directa tras la concesión de 10,000 opciones.
Clene Inc. 보고자 모건 R. 브라운은 임원으로 식별되며(최고재무책임자), 2025년 9월 25일에 10,000주의 보통주에 대한 스톡옵션 수여를 받았고, Clene Inc. Amended 2020 Stock Plan에 따라 주당 행사 가격은 $6.05이다. 수여는 12회의 균등한 월간 분할로 2025년 10월 25일부터 시작하여 완전 vest될 때까지 진행된다. 표는 기초 보통주를 10,000주로 기재하고, 옵션의 기간은 2035년 9월 24일을 참조로 보여준다. Form 4는 수여를 파생증권 취득으로 보고하며, 10,000개의 옵션을 부여 받은 직후 직접 소유권을 나타낸다.
Clene Inc. La personne dénommée par le rapport, Morgan R. Brown, identifiée comme fonctionnaire (Directeur financier), a reçu une attribution d’options sur actions le 25/09/2025 pour 10 000 actions ordinaires dans le cadre du Clene Inc. Amended 2020 Stock Plan, à un prix d’exercice de $6,05 par action. L’attribution veste en 12 versements mensuels égaux à partir du 25/10/2025 jusqu’à ce qu’elle soit entièrement acquise. Le tableau répertorie les actions ordinaires sous-jacentes comme 10 000 et montre la durée de l’option faisant référence au 24/09/2035. Le Form 4 rapporte l’attribution comme une acquisition de valeurs dérivées et indique une propriété directe suite à l’octroi de 10 000 options.
Clene Inc. Die meldende Person Morgan R. Brown, identifiziert als Beauftragter (Chief Financial Officer), erhielt am 25.09.2025 eine Aktienoptionszuteilung über 10.000 Stammaktien gemäß dem Clene Inc. Amended 2020 Stock Plan zu einem Ausübungspreis von $6,05 pro Aktie. Die Zuteilung vested in 12 gleichen monatlichen Raten ab dem 25.10.2025 bis zur vollständigen Vestung. Die Tabelle führt die zugrunde liegenden Stammaktien mit 10.000 auf und zeigt die Optionslaufzeit mit Bezug auf das 24.09.2035. Das Form 4 meldet die Gewährung als Erwerb derivativer Wertpapiere und gibt nach der Gewährung von 10.000 Optionen unmittelbaren Eigentum an.
FAQ
What did the Clene Inc. (CLNN) Form 4 report?
What is the exercise price and quantity of the options granted to the CFO?
When do the options vest and what is the option term?
Who is the reporting person and what is their role at CLNN?
Does the filing state whether ownership is direct or indirect?
